Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism

PHASE4RecruitingINTERVENTIONAL
Enrollment

558

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2028

Conditions
Pulmonary Embolism
Interventions
DRUG

Thrombolytic

Local, catheter-directed thrombolysis with a total dose of 10mg per affected lung administered over 9 hours.

DRUG

Standard anticoagulation

Standard anticoagulation therapy of acute pulmonary embolism.

Trial Locations (1)

100 34

RECRUITING

University Hospital Kralovske Vinohrady, Prague

All Listed Sponsors
collaborator

Charles University

UNKNOWN

collaborator

University Hospital Ostrava

OTHER

collaborator

University Hospital Olomouc

OTHER

collaborator

University Hospital Brno

UNKNOWN

collaborator

St. Anne´s University Hospital Brno

UNKNOWN

collaborator

General University Hospital, Prague

OTHER

collaborator

University Hospital Pilsen

OTHER

collaborator

Pardubice Hospital

UNKNOWN

lead

Faculty Hospital Kralovske Vinohrady

OTHER_GOV

NCT05493163 - Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter